Ethyl 2-amino-4-methyl-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylate, 97%, 5g

5-Iodo-1,2,3-trimethoxybenzene>95.0%(GC)1g

QUINUCLIDINE-2-CARBOXYLIC ACID HYDROCHLORIDE, 95.0%, 100g

(R)-1-(2-Amino-ethyl)-pyrrolidin-3-ol, 95.0%, 1g

Acido 4-idrazinabenzoico, min 97%, per sintesi, 100 g, confezione in vetro

2-Cyclopropyl-5,6,7,8-tetrahydroimidazo[1,2-a]pyrazine hydrochloride, 95.0%, 100mg

tert-Butyl N-[1-(pyrimidin-4-yl)azetidin-3-yl]carbamate, 1g

(4-Chloro-2-methoxyphenyl)methanol, 95.0%, 5g

4,4,5,5-Tetramethyl-2-(spiro[fluorene-9,9'-xanthen]-4-yl)-1,3,2-dioxaborolane, 98%, 1g

Ethyl (4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-yl)carbamate hydrochloride, 98%, 1g

CLINAFLOXACIN, 95%, 100mg

3,5-Dimethylacetophenone, 98.0%, 5g

2-Bromo-6-fluoronaphthalene, 97.0%, 25g